Explanation of antifibrotic Mcpip1 role in the liver

2019/33/N/NZ5/00916

Keywords

Descriptors

  • NZ5_001: Etiologia chorób człowieka
  • NZ5_003: Patogeneza chorób człowieka
  • NZ3_001: Biologia komórki

Panel

NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)

Host institution

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Voivodeship: małopolskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

Natalia Pydyn

Number of co-investigators in the project: 2

Call

PRELUDIUM 17 – announced on 2019-03-15

Amount awarded
139 858 PLN
Project start date
2020-02-20
Project end date
2023-02-19
Project duration
36 months (the same as in the proposal)
Project status
Project settled

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

Publication in academic press/journals (1)

  1. MCPIP1 inhibits hepatic stellate cell activation in autocrine and paracrine manners, preventing liver fibrosis.

    Authors:
    Natalia Pydyn, Anna Ferenc, Katarzyna Trzos, Ewelina Pospiech, Mateusz Wilamowski, Olga Mucha, Piotr Major, Justyna Kadłuczka, Pedro M Rodrigues, Jesus M Banales, Jose M Herranz, Matias A Avila, Tomasz Hutsch, Piotr Malczak, Dorota Radkowiak, Andrzej Budzynski, Jolanta Jura, Jerzy Kotlinowski
    Academic press:
    Cellular and Molecular Gastroenterology and Hepatology (year: 2024, volume: -, pages: -), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.jcmgh.2024.01.021 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski